drugset / Trial / NCT01365052
Safety Trial of Naproxen Sodium/ Diphenhydramine
RandomizedParallel-groupTriple-blind
Summary
The purpose of this trial is to see how safe the combination of naproxen sodium 440 mg and diphenhydramine hydrochloride (DPH) 50 mg (the investigational product) is compared to placebo (capsules containing no drug) when taken for 10 days.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diphenhydramine | Unknown | 50 mg | Oral |
| Subject | Naproxen | Small molecule | 440 mg | Oral |
Indications
No indication recorded.